FTC Has Shot At Victory In Pay-For-Delay Suits: Attys
In two cases the Federal Trade Commission brought challenging so-called reverse payment settlements in the pharmaceutical industry, the agency is looking for victory in a hostile legal landscape — but it...To view the full article, register now.
Already a subscriber? Click here to view full article